Work with NCRI Groups

Get input on your studies

One of the key purposes of the NCRI Groups is to develop and maintain a comprehensive national portfolio of clinical trials and other well-designed studies. One of the ways they do this is by offering an expert voice to trials in development by members of the wider research community to help strengthen studies before they are submitted for funding.

In order to get the most meaningful input from our NCRI Groups at the right time, we’d recommend getting in touch with the Group no later than 6 months before a planned funding submission. This allows time to come and present at an upcoming NCRI Group or Subgroup meeting, depending on what is most appropriate for your study. Closer to the time, we may not be able to guarantee the same level of meaningful input.

To get input from an NCRI Group, please visit the relevant NCRI Group page for contact details.

Submit your proposal to our NCRI Screening, Prevention & Early Diagnosis (SPED) Group

The NCRI SPED Group offers input into trials across the breadth of screening, prevention and early diagnosis research.

The NCRI SPED Group runs two workshops per year, where researchers can submit their proposal for comment from an expert panel with a broad base of expertise in this area. The next call for proposals is March 2019.

Click here to register your interest in the next round of proposals and for more information please visit our NCRI SPED Group page.

Advice on Translational Research

The NCRI aims to stimulate and promote the inclusion of high quality translational research into clinical trials through the sharing of expertise across our many initiatives and research groups. Whether you are in the early stages of clinical trial design or have developed clinical trial proposals, the NCRI can offer advice on the translational element of your trial in the following areas:


The NCRI Clinical Trial Pathology Advisory Group (CTPAG) is a group of over 50 experts that provide guidance and technical critique of pathology and biomarker components in clinical trials. For more information visit


The NCRI’s Clinical and Translational Radiotherapy Research Working Group (CTRad) has a group of radiotherapy experts which can provide advice about particular biomarkers, techniques or methodologies, or about other topics such as translational trial design or data processing. For more information visit

If you require advice on the translational research element of your clinical trial, please contact

Annual Trials Meetings

The majority of our NCRI Groups run Annual Trials Meetings as an opportunity to share with the wider research community the work of the Group; latest trial results; trials coming to a hospital near you soon; high quality talks on cross-cutting themes by international speakers.

Annual Trials Meetings are open to all, and are a great way to keep up to date with the latest developments in your area of research, as well as attracting CPD credits. There is a small delegate fee to attend.

Visit the relevant NCRI Group page to find about upcoming Annual Trials Meetings.